Last reviewed · How we verify

NCT03888287: PICK

Parkinson's Disease Inpatient Clinical Knowledge and Management

Terminated NA Results posted Last updated 18 April 2023
What this trial tests

NA trial testing Watch Rx system in Parkinson Disease in 477 participants. Terminated before completion.

Timeline
1 August 2018
Primary endpoint
3 January 2022
3 January 2022

Quick facts

Lead sponsorHackensack Meridian Health
PhaseNA
StatusTerminated
Study typeINTERVENTIONAL
Allocationnon randomized
Designsingle group
Maskingnone
Primary purposesupportive care
Enrollment477
Start date1 August 2018
Primary completion3 January 2022
Estimated completion3 January 2022
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Hackensack Meridian Health — full company profile →

Who can join

22 and older, any sex, with Parkinson Disease. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Clinician's Parkinson's Disease Knowledge Assessment Survey Scores Primary · 6 months

Clinician's Parkinson's Disease Knowledge Assessment Survey scores before and after the Parkinson's Disease Inpatient Clinical Knowledge and Management Program. A 20-question survey was administered to PD clinicians for a group measurement of PD knowledge. Scores ranged from 0 - 100% and reflected the percentage of clinicians who correctly answered the question. If 70% or more clinicians correctly answered the question, the group was considered knowledgeable on that topic; if \<70% of clinicians responded incorrectly, they were considered not knowledgeable on the information that the question

GroupValue95% CI
Clinicians' Knowledge Before Educational Intervention68.500 – 100
Clinicians' Knowledge After Educational Intervention78.750 – 100
Number of PD Medications Administered on Time (15 Minute Window) Secondary · within 15 minutes post PD medication administration time

The number of Parkinson's Disease (PD) medications administered within the 15-minute timeframe at baseline

GroupValue95% CI
Retrospective Patient Outcomes678
Number of Patients With Contraindicated Medications Administered. Secondary · 6 months

Measure the number of patients who were adminstered contraindicated medications

GroupValue95% CI
Retrospective Patient Outcomes21
Number Patients With Falls, Falls With Injury, Positive CAM/Mini-cog Secondary · 6 Months

The number of falls, number of falls with injury, and number of patients with positive Confusion Assessment Method (CAM)/Mini-Cog scores) in hospitalized patients. Mini-cog is performed on all admitted patients 65 years and older and is a quick screening for "cognitive vital sign" and early dementia detection. The scale classifies patients as being positive or negative for dementia. The Confusion Assessment Method (CAM) is performed on all adult admissions at the time of admission with reporting 1) every shift if the first test is positive, or 2) daily if the first test is negative. It impro

Number of falls
GroupValue95% CI
Retrospective Patient Outcomes1
Number of falls with injury
GroupValue95% CI
Retrospective Patient Outcomes0
Number of patients with positive CAM scores
GroupValue95% CI
Retrospective Patient Outcomes47
Number of patients with abnormal mini-cog scores
GroupValue95% CI
Retrospective Patient Outcomes45
Length of Stay in Hospitalized Parkinson's Disease Patients. Secondary · 6 months

Average length of stay in hospitalized Parkinson's Disease patients

GroupValue95% CI
Retrospective Patient Outcomes6.1± 6.6

Sponsor's own description

This study will focus on patients with Parkinson's Disease in the adult inpatient units of Hackensack University Medical Center. We are measuring the effect of a Parkinson's Disease Inpatient Clinical Knowledge and Management Program on adherence to Parkinson's Disease medication using a Parkinson's Disease Identification Wrist Band, smartwatch and medication schedule card

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Parkinson Disease

Currently open trials in the same condition.

Other Hackensack Meridian Health trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03888287.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing